Literature DB >> 24584917

Can we decide which outcomes should be measured in every clinical trial? A scoping review of the existing conceptual frameworks and processes to develop core outcome sets.

Leanne Idzerda1, Tamara Rader, Peter Tugwell, Maarten Boers.   

Abstract

OBJECTIVE: The usefulness of randomized control trials to advance clinical care depends upon the outcomes reported, but disagreement on the choice of outcome measures has resulted in inconsistency and the potential for reporting bias. One solution to this problem is the development of a core outcome set: a minimum set of outcome measures deemed critical for clinical decision making. Within rheumatology the Outcome Measures in Rheumatology (OMERACT) initiative has pioneered the development of core outcome sets since 1992. As the number of diseases addressed by OMERACT has increased and its experience in formulating core sets has grown, clarification and update of the conceptual framework and formulation of a more explicit process of area/domain core set development has become necessary. As part of the update process of the OMERACT Filter criteria to version 2, a literature review was undertaken to compare and contrast the OMERACT conceptual framework with others within and outside rheumatology.
METHODS: A scoping search was undertaken to examine the extent, range, and nature of conceptual frameworks for core set outcome selection in health. We searched the following resources: Cochrane Library Methods Group Register; Medline; Embase; PsycInfo; Environmental Studies and Policy Collection; and ABI/INFORM Global. We also conducted a targeted Google search.
RESULTS: Five conceptual frameworks were identified: the WHO tripartite definition of health; the 5 Ds (discomfort, disability, drug toxicity, dollar cost, and death); the International Classification of Functioning (ICF); PROMIS (Patient-Reported Outcomes Measurement System); and the Outcomes Hierarchy. Of these, only the 5 Ds and ICF frameworks have been systematically applied in core set development. Outside the area of rheumatology, several core sets were identified; these had been developed through a limited range of consensus-based methods with varying degrees of methodological rigor. None applied a framework to ensure content validity of the end product.
CONCLUSION: This scoping review reinforced the need for clear methods and standards for core set development. Based on these findings, OMERACT will make its own conceptual framework and working process more explicit. Proposals for how to achieve this were discussed at the OMERACT 11 conference.

Entities:  

Keywords:  CLINICAL TRIALS; CORE OUTCOME SETS; OMERACT 11; OUTCOME AND PROCESS ASSESSMENT

Mesh:

Year:  2014        PMID: 24584917     DOI: 10.3899/jrheum.131308

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  16 in total

Review 1.  Measuring Functional and Patient-Reported Outcomes After Treatment of Mutilating Hand Injuries: A Global Health Approach.

Authors:  Aviram M Giladi; Kavitha Ranganathan; Kevin C Chung
Journal:  Hand Clin       Date:  2016-11       Impact factor: 1.907

Review 2.  The COMET Handbook: version 1.0.

Authors:  Paula R Williamson; Douglas G Altman; Heather Bagley; Karen L Barnes; Jane M Blazeby; Sara T Brookes; Mike Clarke; Elizabeth Gargon; Sarah Gorst; Nicola Harman; Jamie J Kirkham; Angus McNair; Cecilia A C Prinsen; Jochen Schmitt; Caroline B Terwee; Bridget Young
Journal:  Trials       Date:  2017-06-20       Impact factor: 2.279

3.  Updating the OMERACT filter: core areas as a basis for defining core outcome sets.

Authors:  John R Kirwan; Maarten Boers; Sarah Hewlett; Dorcas Beaton; Clifton O Bingham; Ernest Choy; Philip G Conaghan; Maria-Antonietta D'Agostino; Maxime Dougados; Daniel E Furst; Francis Guillemin; Laure Gossec; Désirée M van der Heijde; Margreet Kloppenburg; Tore K Kvien; Robert B M Landewé; Sarah L Mackie; Eric L Matteson; Philip J Mease; Peter A Merkel; Mikkel Ostergaard; Lesley Ann Saketkoo; Lee Simon; Jasvinder A Singh; Vibeke Strand; Peter Tugwell
Journal:  J Rheumatol       Date:  2014-03-15       Impact factor: 4.666

4.  [Clinical studies on multimodal pain therapy : Standardized measurement of therapy outcomes with a core outcome set].

Authors:  S Deckert; R Sabatowski; J Schmitt; U Kaiser
Journal:  Schmerz       Date:  2016-12       Impact factor: 1.107

Review 5.  A systematic review of the outcomes reported in trials of medication review in older patients: the need for a core outcome set.

Authors:  Jean-Baptiste Beuscart; Lisa G Pont; Stefanie Thevelin; Benoit Boland; Olivia Dalleur; Anne W S Rutjes; Johanna I Westbrook; Anne Spinewine
Journal:  Br J Clin Pharmacol       Date:  2017-01-18       Impact factor: 4.335

Review 6.  Outcome Measurement in ICU Survivorship Research From 1970 to 2013: A Scoping Review of 425 Publications.

Authors:  Alison E Turnbull; Anahita Rabiee; Wesley E Davis; Mohamed Farhan Nasser; Venkat Reddy Venna; Rohini Lolitha; Ramona O Hopkins; O Joseph Bienvenu; Karen A Robinson; Dale M Needham
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

7.  Establishing clinical severity for PROMIS® measures in adult patients with rheumatic diseases.

Authors:  Vivek Nagaraja; Constance Mara; Puja P Khanna; Rajaie Namas; Amber Young; David A Fox; Timothy Laing; William J McCune; Carol Dodge; Debra Rizzo; Maha Almackenzie; Dinesh Khanna
Journal:  Qual Life Res       Date:  2017-10-05       Impact factor: 4.147

8.  A core outcome set for clinical trials on non-specific low back pain: study protocol for the development of a core domain set.

Authors:  Alessandro Chiarotto; Caroline B Terwee; Richard A Deyo; Maarten Boers; Chung-Wei Christine Lin; Rachelle Buchbinder; Terry P Corbin; Leonardo O P Costa; Nadine E Foster; Margreth Grotle; Bart W Koes; Francisco M Kovacs; Chris G Maher; Adam M Pearson; Wilco C Peul; Mark L Schoene; Dennis C Turk; Maurits W van Tulder; Raymond W Ostelo
Journal:  Trials       Date:  2014-12-26       Impact factor: 2.279

Review 9.  Core Outcome Sets and Multidimensional Assessment Tools for Harmonizing Outcome Measure in Chronic Pain and Back Pain.

Authors:  Ulrike Kaiser; Katrin Neustadt; Christian Kopkow; Jochen Schmitt; Rainer Sabatowski
Journal:  Healthcare (Basel)       Date:  2016-08-29

10.  Validation and application of a core set of patient-relevant outcome domains to assess the effectiveness of multimodal pain therapy (VAPAIN): a study protocol.

Authors:  Ulrike Kaiser; Christian Kopkow; Stefanie Deckert; Rainer Sabatowski; Jochen Schmitt
Journal:  BMJ Open       Date:  2015-11-06       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.